Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-22-018942

President & CEO bought 144,666 shares at an average $1.94 ($280,943)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Quinn Anthony G. President & CEO 2022-03-11 Purchase +34,777 $2.06 $71,780 363,572 D: show line 1 in the form
Quinn Anthony G. President & CEO 2022-03-14 Purchase +67,472 $1.93 $130,221 431,044 D: show line 2 in the form
Quinn Anthony G. President & CEO 2022-03-15 Purchase +42,417 $1.86 $78,942 473,461 D: show line 3 in the form
Open-market purchases · 144,666 sh · avg $1.94 · $280,943
Loading xslF345X03/doc4.xml…